News for 'Chemicals'

Glenmark may beat rivals in chemical entity sale

Glenmark may beat rivals in chemical entity sale

Rediff.com23 Dec 2008

Glenmark plans to start selling its anti-diarrhoea drug, Crofelemer, by the first-half of 2010 across the globe, except in North America, Europe, Japan and China, the company said. The confidence to sell the drug ahead of its rivals comes as the Crofelemer's original developer, Napo Pharmaceutical Inc, recently entered into a tie-up with a US-based drug maker, Salyx, for selling the drug in the US market, paving the way for Glenmark to sell it in the rest of the world.

Emerging AI: What Awaits Us?

Emerging AI: What Awaits Us?

Rediff.com13 Dec 2022

Ajit Balakrishnan offers lessons from another tech revolution not so long ago.

Wholesale price-based inflation cools to 4.95% in Dec

Wholesale price-based inflation cools to 4.95% in Dec

Rediff.com16 Jan 2023

The wholesale price-based inflation declined to 4.95 per cent in December 2022, mainly due to fall in prices of food articles and crude petroleum. The Wholesale Price Index (WPI)-based inflation was 5.85 per cent in November 2022 and 14.27 per cent in December 2021. Inflation in food articles was (-)1.25 per cent, while in fuel and power it was 18.09 per cent during December 2022.

'Market is headed for an eventful 2024'

'Market is headed for an eventful 2024'

Rediff.com29 Jan 2024

'Higher valuation remains the only spoiler for equities.'

No salary for Akash, Isha and Anant Ambani; fee for attending board meetings

No salary for Akash, Isha and Anant Ambani; fee for attending board meetings

Rediff.com26 Sep 2023

While Ambani, 66, drew nil salary from the company since the 2020-21 fiscal year, other executive directors including his cousins Nikhil and Hital are paid a salary, perquisites, allowances and commission. His three children - twins Akash and Isha (both 31) and Anant (28 years) - will get only a sitting fee and a commission on the profit earned by the firm.

J&K militants have chemical weapons: Army

J&K militants have chemical weapons: Army

Rediff.com30 Apr 2003

Lieutenant Colonel S P K Singh of the Northern Command Headquarters said intelligence intercepts reveal that terrorists have been talking about the use of poisonous gas.

Will BJP benefit from Trinamool leader's arrest for Sandeshkhali?

Will BJP benefit from Trinamool leader's arrest for Sandeshkhali?

Rediff.com14 Mar 2024

Whether the age-old cry of kendrer banchana will be able to drown out pangs of Sandeshkhali, the EVM will tell.

Mcap club: Tata group remains No 1; Murugappa, JSW in top 10

Mcap club: Tata group remains No 1; Murugappa, JSW in top 10

Rediff.com15 Jan 2024

Tata Group remained India's largest business conglomerate in market capitalisation in calendar year 2023 while the Mukesh Ambani camp raced ahead of the Adani businesses to become the second-largest. The Tata companies ended 2023 with a combined group market capitalisation of Rs 28.68 trillion, up 35 per cent from the Rs 21.2 trillion at the end of December 2022. Ambani's group mcap is Rs 19.42 trillion at the end of CY23, up 10.7 per cent from the Rs 17.6 trillion a year ago.

10 Photographs You HAVE To See Today

10 Photographs You HAVE To See Today

Rediff.com13 Mar 2024

The ten best pics of 2023.

Mock terror and chemical 'attacks' on Delhi Metro

Mock terror and chemical 'attacks' on Delhi Metro

Rediff.com14 Feb 2008

Monitored by the National Disaster Management Authority, the mock drills were carried out simultaneously at Rajiv Chowk (terror attack), Chawri Bazar (toxic gas release), Rithala (bomb blast at parking area) and Shastri Park (call about planting of bomb at train depot) at around 6:15 am.

Who is India's BIGGEST wealth creator?

Who is India's BIGGEST wealth creator?

Rediff.com17 Dec 2023

Reliance Industries Ltd was the biggest wealth creator during the five-year period from 2018 to 2023 while Adani Enterprises Ltd was the top all-round wealth creator, according to a study by Motilal Oswal Financial Services. The study, based on stock market performance of companies, said for the fifth time in succession, Reliance emerged as the largest wealth creator, adding Rs 9,63,800 crore wealth over 2018-23. It was followed by Tata Consultancy Services (Rs 6,77,400 crore wealth addition), ICICI Bank (Rs 4,15,500 crore), Infosys (Rs 3,61,800 crore) and Bharti Airtel (Rs 2,80,800 crore).

IOA concerned at 2012 Games link with Dow Chemical

IOA concerned at 2012 Games link with Dow Chemical

Rediff.com9 Aug 2011

The Indian Olympic Association on Monday expressed deep concern at Dow Chemical Company's sponsorship role in the 2012 London Olympics and said it would write to the organisers to reconsider the decision.

Bihar battles dengue spike, reports over 6,000 cases in Sept; highest in 5 yrs

Bihar battles dengue spike, reports over 6,000 cases in Sept; highest in 5 yrs

Rediff.com1 Oct 2023

The state had reported 6,421 cases this year, of which 6,146 were reported only in September, three times the 1,896 registered in September last year.

Rollout of new PLIs unlikely as govt eyes 'course correction'

Rollout of new PLIs unlikely as govt eyes 'course correction'

Rediff.com14 Oct 2023

The government has decided to hold off introducing the production-linked incentive (PLI) scheme for additional sectors until it verifies the efficacy of existing initiatives. Top government officials have received mixed feedback on the scheme, including insights from the Economic Advisory Council to the Prime Minister, people aware of the matter said. "There are no new PLI schemes in the offing.

US works on Syria attack plan, releases videos of chemical attack

US works on Syria attack plan, releases videos of chemical attack

Rediff.com8 Sep 2013

A United States Senate Intelligence Panel has released 13 videos showing images of the chemical attack in Syria allegedly carried out by President Bashar al-Assad's regime, as the White House pressed its case for military action in the strife-torn country.

Blast near Israeli embassy: What the cops have found so far

Blast near Israeli embassy: What the cops have found so far

Rediff.com27 Dec 2023

Officials probing a blast that occurred near the Israeli embassy in New Delhi suspect it was a well-orchestrated plan, knowing that no CCTV camera was installed on Prithviraj Road, police sources said on Wednesday.

Q1 a washout, exporters pin hope on North America for a turnaround

Q1 a washout, exporters pin hope on North America for a turnaround

Rediff.com3 Aug 2023

After the first quarter was washed out, exporters are now keeping their fingers crossed over a turnaround in outbound shipments to at least North America from September onwards. This comes even as other key destinations such as Europe may take longer to revive in FY24. Slowdown in key economies, as well as geopolitical tensions resulted in sluggish demand for Indian goods.

Best Career Options For Science Students

Best Career Options For Science Students

Rediff.com3 Jan 2024

rediffGURU Mayank Kumar offers guidance about degree courses, campus, job-linked and executive programmes and studying abroad.

'We were listed in the global top 10 start-ups in sustainability'

'We were listed in the global top 10 start-ups in sustainability'

Rediff.com8 Feb 2024

'We want to make sustainability affordable.' 'We tell everyone, don't just recycle, Craste it!'

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Rediff.com30 Jan 2024

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for niche drugs in the US market, fall in raw material prices and correction in shipping rates. In the healthcare segment, hospitals are expected to post revenue growth of 13 per cent during the coverage, while net profit growth would be around 37 per cent, ICICI Securities said in a note. However, the performance may not be comparable on a sequential basis due to the offset of the festive season in Q3FY24, the analysts noted.

No attempt to sway India on Dow Chemical: US

No attempt to sway India on Dow Chemical: US

Rediff.com20 Aug 2010

The apparent linkage had been implied by a report on the Times Now news channel that disclosed an email exchange between US Deputy National Security Advisor for International Economic Affairs Michael Froman and Deputy Chairman of the Planning Commission Montek Singh Ahluwalia.

RIL's new energy business piques analysts' interest

RIL's new energy business piques analysts' interest

Rediff.com18 Dec 2023

For the company's latest energy initiative to expand its green energy and storage portfolio, some analysts are beginning to suggest a closer look at some of its segments. In his address to shareholders in the company's FY22 annual report, billionaire Mukesh Ambani, chairman and managing director of the company, said: "The green energy value holds great promise to outshine all our existing growth engines in just 5-7 years." The company has marked an investment of Rs 75,000 crore towards its new energy plans, which include solar energy value chain, green hydrogen, energy storage and other similar businesses.

Chided by BJP MP, Delhi Jal Board official bathes in Yamuna

Chided by BJP MP, Delhi Jal Board official bathes in Yamuna

Rediff.com30 Oct 2022

A senior Delhi Jal Board (DJB) official on Sunday bathed in water taken from a stretch of the Yamuna where the utility sprayed a chemical to dissipate foam in the river.

SEE: Face of Ram Lalla idol at Ayodhya temple revealed

SEE: Face of Ram Lalla idol at Ayodhya temple revealed

Rediff.com19 Jan 2024

The new idol of Lord Ram was placed in the sanctum sanctorum of Ayodhya's Ram Janmabhoomi temple on Thursday afternoon, ahead of the January 22 consecration ceremony.

Indigenously-built missile destroyer INS Imphal to be commissioned on Tuesday

Indigenously-built missile destroyer INS Imphal to be commissioned on Tuesday

Rediff.com24 Dec 2023

It is the first warship to have been named after a city from the Northeastern region, the approval for which was accorded by the President in April 2019.

« Prev  |